Glinide
32 drugs across 11 manufacturers|32 Generic,0 Brand
The Glinide class contains 32 NDCs from 11 manufacturers (32 generic, 0 brand), at an average NADAC of $0.15 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.
Total Drugs
32
32G / 0B
Manufacturers
11
Avg $0.1460/unit
Avg 7d Change
-1.46%
Across 31 drugs with changes
7d Activity
of 32 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Manufacturer Breakdown
11 manufacturers producing drugs in this therapeutic class
Follow this class across the site
These links connect the therapeutic class page to the specific suppliers, markets, and trend surfaces that help users keep exploring.
Top supplier
Rising Pharma Holdings Inc. manufacturer profile
Review the supplier with the strongest product footprint inside this therapeutic class.
Lead market
Repaglinide market page
Move from the therapeutic class into the molecule that appears most often in this class-specific portfolio.
Trend hub
Latest trend hub
Compare this class against the rest of the weekly NADAC trend surface.
Guide
Understanding NADAC pricing
Use the explainer when you need a plain-English refresher on how these class-level numbers are published and interpreted.
Frequently Asked Questions
How many drugs are in the Glinide class?
The Glinide class contains 32 NDCs from 11 manufacturers — 32 generic and 0 brand products.
What is the average price of Glinide drugs?
The average NADAC for the Glinide class is $0.1460 per unit across 32 NDCs.
Which manufacturers make Glinide drugs?
11 manufacturers make drugs in the Glinide class. Ranked by number of NDCs, the largest are Rising Pharma Holdings Inc. (5), Modavar Pharmaceuticals LLC (4), American Health Packaging (3), Macleods Pharmaceuticals Limited (3), Chartwell RX LLC (3).
How has Glinide pricing changed recently?
Over the past 7 days, 11 NDCs in this class rose and 20 fell, with a class-wide average change of -1.5%.